Islah Ahmed

Islah Ahmed has a diverse and extensive work experience in the pharmaceutical industry. They began their career as a researcher at the NY Institute for Medical Research in 1986. They then moved on to work at Omnicare CR as a Senior Medical Director, where they focused on business development and medical consulting for clinical development plans. They were responsible for managing full-service programs and successfully filing multiple INDs. In 2004, they joined Hospira as a Senior Medical Director, leading clinical development strategies for a range of therapeutic areas and participating in regulatory authority meetings. They also directed Medical Affairs for new product launches in Europe. From 2011 to 2020, Islah worked at Johnson and Johnson, where they held the position of Senior Safety Officer and Senior Director. In this role, they managed cross-functional teams and provided strategic direction for safety assessments and risk management. They also played a key role in new product development and ensured compliance with regulatory guidelines. In 2020, Islah became self-employed as a Senior Consultant, specializing in clinical product development and pharmacovigilance. They worked with various pharmaceutical and healthcare companies, utilizing their expertise in safety evaluation and benefit-risk management. Lastly, since 2020, Islah has been working at Intercept Pharmaceuticals, first as an Executive Director and currently as the Vice President of Medical Safety & Pharmacovigilance.

Islah Ahmed attended Dow Medical College in Karachi, Pakistan from 1976 to 1982, where they earned a degree in Medicine and Surgery. The next education history entry is for The College of Saint Rose, however, there is no information provided regarding the start and end years of attendance or the field of study.